lactic acid has been researched along with pulmicort in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bandi, N; Kompella, UB; Martin, TM; Roberts, CB; Shulz, R | 1 |
| Ciach, T | 1 |
| Arya, V; Brugos, B; Coowanitwong, I; Hochhaus, G; Kim, WS; Singh, R | 1 |
| Krishnamachari, Y; Lin, S; Madan, P | 1 |
| Arya, V; Coowanitwong, I; Craciun, V; Hochhaus, G; Kim, WS; Patel, G; Rocca, JR; Singh, R | 1 |
| Misra, A; Surti, N | 1 |
| Bai, MY; Chen, DR; Lee, YH; Mei, F; Zhao, S | 1 |
| Bai, MY; Chen, DR; Lee, YH | 1 |
| Kim, SH; Lee, J; Lee, KY; Oh, YJ; Rhim, T; Seo, JY; Yoon, HJ | 1 |
| Ali, H; Collnot, EM; Crielaard, BJ; Lammers, T; Lehr, CM; Leonard, F; Storm, G | 1 |
| Ali, H; Collnot, EM; Lehr, CM; Neurath, MF; Weigmann, B; Windbergs, M | 1 |
| Amani, A; Amini, MA; Esmaeilzadeh-Gharehdaghi, E; Faramarzi, MA; Gilani, K; Moazeni, E | 1 |
| Ali, H; Collnot, EM; Khan, SA; Lehr, CM; Weigmann, B; Windbergs, M | 1 |
| Chen, DR; Yeh, HW | 1 |
15 other study(ies) available for lactic acid and pulmicort
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.
Topics: Budesonide; Calorimetry, Differential Scanning; Capsules; Carbon Dioxide; Chemical Precipitation; Delayed-Action Preparations; Dialysis; Diffusion; Drug Compounding; Flow Injection Analysis; Lactic Acid; Microscopy, Electron, Scanning; Polyesters; Polymers; Solutions; Temperature | 2002 |
Microencapsulation of drugs by electro-hydro-dynamic atomization.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Budesonide; Drug Compounding; Electrochemistry; Glucocorticoids; Indicators and Reagents; Lactic Acid; Paclitaxel; Particle Size; Polyesters; Polymers; Solubility; Solvents | 2006 |
Pulmonary targeting of sustained release formulation of budesonide in neonatal rats.
Topics: Animals; Animals, Newborn; Area Under Curve; Brain; Bronchodilator Agents; Budesonide; Excipients; Lactic Acid; Liver; Lung; Polyesters; Polymers; Powders; Rats; Receptors, Glucocorticoid; Solubility; Suspensions; Tissue Distribution | 2006 |
Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Topics: Administration, Oral; Budesonide; Colon; Drug Delivery Systems; Hydrogen-Ion Concentration; Ileum; Lactic Acid; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polymethacrylic Acids; Solubility | 2007 |
Laser-ablated nanofunctional polymers for the formulation of slow-release powders for dry powder inhalers: physicochemical characterization and slow-release characteristics.
Topics: Administration, Inhalation; Aerosols; Animals; Budesonide; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Stability; Glucocorticoids; Humans; Lactic Acid; Lasers; Lung; Polyesters; Polymers; Powders; Rats; Rats, Inbred F344; Solubility; Time Factors; Triamcinolone Acetonide | 2007 |
Wheat germ agglutinin-conjugated nanoparticles for sustained cellular and lung delivery of budesonide.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Budesonide; Cell Cycle; Cell Proliferation; Cells, Cultured; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coumarins; Drug Delivery Systems; Excipients; Intubation, Intratracheal; Lactic Acid; Lung; Male; Microscopy, Confocal; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Wheat Germ Agglutinins | 2008 |
Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray.
Topics: Budesonide; Coated Materials, Biocompatible; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Compounding; Electric Conductivity; Equipment Design; Lactic Acid; Microscopy, Electron, Scanning; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties | 2010 |
Multidrug encapsulation by coaxial tri-capillary electrospray.
Topics: Budesonide; Drug Delivery Systems; Electrochemical Techniques; Lactic Acid; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polystyrenes; Rheology | 2011 |
Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Topics: Animals; Asthma; Bicarbonates; Bronchodilator Agents; Budesonide; Drug Carriers; Female; Lactic Acid; Lung; Mice; Mice, Inbred BALB C; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity | 2011 |
Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model.
Topics: Animal Testing Alternatives; Anti-Inflammatory Agents; Budesonide; Caco-2 Cells; Cells, Cultured; Coculture Techniques; Dendritic Cells; Humans; Inflammatory Bowel Diseases; Interleukin-1beta; Interleukin-8; Lactic Acid; Liposomes; Macrophages; Microscopy, Confocal; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2012 |
Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases.
Topics: Animals; Anti-Inflammatory Agents; Budesonide; Cytokines; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactic Acid; Methylmethacrylate; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2014 |
Production, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles.
Topics: Aerosols; Anti-Inflammatory Agents; Budesonide; Lactic Acid; Nanoparticles; Nebulizers and Vaporizers; Particle Size; Polyesters; Polymers | 2014 |
Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
Topics: Animals; Anti-Inflammatory Agents; Budesonide; Colitis; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Intestinal Mucosa; Lactic Acid; Mice, Inbred BALB C; Nanoparticles; Optical Imaging; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; X-Ray Diffraction | 2016 |
In vitro release profiles of PLGA core-shell composite particles loaded with theophylline and budesonide.
Topics: Budesonide; Drug Liberation; Lactic Acid; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Theophylline | 2017 |